IQVIA’s Christina Mack Named 2023 PharmaVoice 100 Honoree
IQVIA™ (NYSE:IQV), a global provider of data, analytics, technology solutions and services to the life sciences industry, announced that Dr. Christina Mack, chief scientific officer, has been named to the 2023 PharmaVoice 100 list.
- IQVIA™ (NYSE:IQV), a global provider of data, analytics, technology solutions and services to the life sciences industry, announced that Dr. Christina Mack, chief scientific officer, has been named to the 2023 PharmaVoice 100 list.
- Christina Mack and her fellow honorees inspire advancements by guiding their teams, supporting their patients, and propelling their organizations’ missions forward.
- We are excited to recognize their contributions through this annual list,” said Meagan Parrish, lead editor of PharmaVoice.
- The work we do together is pushing new boundaries in science and technology to improve population health and patient outcomes,” said Dr. Mack.